ZymoChem offers a carbon-efficient bio-manufacturing platform built on proprietary Carbon Conserving (C2) microbes. Its microbes convert renewable feedstocks into a variety of high-performance, bio-based, biodegradable polymers via a proprietary fermentation process that yields near-zero CO2 emissions. The company says its process can improve yield by up to 50% versus alternative processes, creating a cost advantage. ZymoChem promotes bio-based manufacturing through partnerships across the value chain and provides drop-in solutions for existing infrastructure. Led by CEO Harshal Chokhawala, the company says its technology has already catalyzed multiple partnerships with world-leading companies. ZymoChem intends to use new funding to expand operations and its business reach. ZymoChem develops Carbon Conserving (C2) microbes and processes that convert renewable feedstocks into high-value, biodegradable bio-based materials intended to replace petroleum-based ingredients in consumer goods. The company emphasizes cost, performance, scale, and sustainability while minimizing CO2 loss during production. ZymoChem was founded in 2015 and is headquartered in San Leandro, California, with a satellite division in Burlington, Vermont. Its technology targets near-term chemical commercialization via fermentation and downstream purification to produce low-cost, high-performing materials derived from sugars. In 2023 ZymoChem was selected for the Department of Defense's BioMADE program and has now received DOE support to advance bioprocessing research and scale-up. The company aims to contribute to industrial decarbonization, job creation, support for underserved economies, and growth of the U.S. bioeconomy. ZymoChem develops microbes and bioprocesses to produce eco-friendly chemicals from renewable feedstocks such as sugar. The company's work focuses on engineering microbial strains and bioprocess routes for sustainable chemical production. ZymoChem closed a $350,000 seed round according to the article. Early-stage investor Breakout Labs was the sole investor in that round. The article does not report any operating metrics, location, founding year, or prior financings. No use-of-proceeds or detailed strategic plans were disclosed in the coverage.

Total raised

$25M

Funding rounds

3

Latest round

Series A

Latest activity

Jan 2024